WHO Prequalification of Indigenous HPV Vaccine Cervavac
Source:The Hindu ↗
কেন এটি গুরুত্বপূর্ণ
The WHO prequalification of an indigenous HPV vaccine like CERVAVAC is a major boost to India's pharmaceutical sector ("Pharmacy of the World") and global health equity, making life-saving cancer-prevention vaccines more accessible and affordable worldwide.
সারসংক্ষেপ
The World Health Organization (WHO) has granted prequalification to CERVAVAC, a quadrivalent human papillomavirus (qHPV) vaccine developed indigenously by the Serum Institute of India (SII). Designed to prevent cervical cancer and other HPV-related diseases, this WHO prequalification enables global procurement agencies such as UNICEF and GAVI to supply the vaccine to low- and middle-income countries. The development underscores India's prowess in affordable vaccine manufacturing, biotechnology innovation, and its critical role in international public health security.
মূল বিষয়
- The World Health Organization (WHO) has prequalified CERVAVAC, India's first indigenous quadrivalent human papillomavirus (qHPV) vaccine developed by the Serum Institute of India (SII).
- CERVAVAC is designed to protect against cervical cancer caused by specific strains of the Human Papillomavirus (HPV), primarily HPV types 16, 18, 6, and 11.
- WHO prequalification allows international organizations like UNICEF and GAVI to procure the vaccine for global immunization programs, enhancing access and affordability in low- and middle-income countries.
- This milestone highlights India's growing capability in biopharmaceutical research, indigenous vaccine manufacturing, and global public health leadership.
গুরুত্বপূর্ণ শব্দ
CERVAVAC
India's first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine, created by the Serum Institute of India to prevent cervical and other HPV-related cancers.
UPSC context
UPSC GS Paper III (Science & Technology - Indigenization of Technology & Biotechnology); tests knowledge of domestic medical innovation and public health milestones.
WHO Prequalification
A rigorous quality, safety, and efficacy assessment system operated by the UN health agency that enables international procurement agencies like UNICEF to acquire vaccines for developing nations.
UPSC context
UPSC GS Paper II (International Relations & Global Health Governance); tests understanding of international standards, global health bodies, and supply chains.
Serum Institute of India
The world's largest vaccine manufacturer by volume, based in Pune, India, known for producing affordable life-saving immunizations for global public health.
UPSC context
UPSC GS Paper III (Economy/S&T); highlights India's position as the 'Pharmacy of the World' and capabilities in pharmaceutical manufacturing.
সংযুক্ত স্থির ধারণা
What is the significance and standard process of WHO Vaccine Prequalification?
- Global Benchmark: WHO assessment ensures vaccines supplied by UN agencies are safe, effective, and manufactured meeting stringent international standards.
- Procurement Gateway: Prequalification is a prerequisite for procurement by international agencies like UNICEF and GAVI for immunization programs in developing nations.
- Rigorous Audit: Involves rigorous evaluation of clinical data, manufacturing site audits, and lot testing to guarantee consistent quality.
আন্তঃবিষয় প্যাটার্ন
Indigenization + Public Health Diplomacy
CERVAVAC's global distribution via GAVI/UNICEF demonstrates how India's domestic biotech R&D directly supports its soft-power and 'Pharmacy of the World' diplomacy in the Global South.
Expect statement questions on WHO prequalification criteria (quality, safety, efficacy) paired with indigenous vaccine development partnerships (DBT-BIRAC).
সংযুক্ত PYQ · 1
সংযুক্ত PYQ · 1
- 2022MainsGS3
What is the basic principle behind vaccine development ? How do vaccines work? What approaches were adopted by the Indian vaccine manufacturers to produce COVID-19 vaccines ?
